Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT

AP11 Limited reported a 5.40% stake in Sagimet Biosciences Inc. - Series A (Schedule 13G)

Event Dec 31, 2023 · Filed May 20, 2025

AP11 Limited reported a 5.40% stake in Sagimet Biosciences Inc. - Series A, 1,654,701 shares, as a passive investor on Dec 31, 2023. Filed May 20, 2025 (Schedule 13G).

Stake
5.40%
Shares
1,654,701
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
AP11 Limited5.40%1,654,701
Ascletis Pharma Inc.5.40%1,654,701

Source

View original at SEC

Related